An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT03407482. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Open-Label Extension Study of Patients Previously Enrolled in Study GA30044 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase II, multicenter, open-label extension (OLE) study will evaluate the long-term safety and efficacy of GDC-0853 in participants with systemic lupus erythematosus (SLE) who have completed Study GA30044 (NCT02908100) up to 48 weeks.
Study identification
- NCT ID
- NCT03407482
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 76 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 9, 2018 (Actual)
- Primary completion
- Nov 20, 2019 (Actual)
- Completion
- Nov 20, 2019 (Actual)
- Last update posted
- Dec 19, 2020
2018 – 2019
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valerius Medical Group | Los Alamitos | California | 90720 | — |
| RASF-Clinical Research Center | Boca Raton | Florida | 33486 | — |
| Bay Area Arthritis and Osteoporosis | Brandon | Florida | 33511 | — |
| Clinical Research of West Florida | Clearwater | Florida | 33765 | — |
| Institute of Arthritis Research | Idaho Falls | Idaho | 83404 | — |
| Ochsner Clinic Foundation | Baton Rouge | Louisiana | 70809 | — |
| Shanahan Rheumatology & Immunology, PLLC | Raleigh | North Carolina | 27617 | — |
| Tekton Research Inc | Austin | Texas | 78745 | — |
| Accurate Clinical Research | Houston | Texas | 77058-3675 | — |
| Accurate Clinical Research | Houston | Texas | 77089 | — |
| Arthritis Clinic Of Central Texas | San Marcos | Texas | 78666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03407482, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2020 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03407482 live on ClinicalTrials.gov.